Speakers

Expand/Collapse

Kenneth S. Loveday
Principal Investigator
Biogen

Natasha Penner
Director, Clinical Pharmacology and Pharmacometrics
Biogen

Björn Bauer
Associate Professor
University of Kentucky

Allan Jensen
Senior Director, Biotherapeutic Discovery
Lundbeck

Andrew Goodearl
Senior Director, Biologics Discovery Group
AbbVie

Mathias Schmidt
Chief Executive Officer
ArmaGen

Graham Marsh
Scientist I, Translational Biology
Biogen

Hao Cai
Associate Scientist
Genentech

Sophie Parmentier Batteur
Director, Neurodegenerative Diseases Discovery
Merck

Mario Mezler
Principle Scientist
AbbVie

Thomas Cameron
Associate Director, Biologics Drug Discovery
Biogen

Choi-Fong Cho
Instructor in Neurosurgery
Harvard Medical School

Danica Stanimirovic
Director, Translational Bioscience Department, Human Health Therapeutics
Research Centre, National Research Council of Canada

Frank Walsh
Chief Executive Officer
Ossianix

Larry Brown
Executive Vice President & Chief Scientific Officer
Noveome Biotherapeutics

Nathan Yoganathan
President & Chief Scientific Officer
KalGene Pharmaceuticals

Susan Rosenbaum
Founder, Chairman & Chief Executive Officer
Lauren Sciences LLC